Clozapine prescribing during follow-up of a first-episode psychosis cohort
Introduction Of those with schizophrenia, one third develop treatment-resistant illness. Nearly 60% of these benefit from clozapine- the only antipsychotic medication licensed in this group. Objectives As treatment-resistant illness developed in the follow-up of a first-episode psychosis (FEP) c...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cambridge University Press
2021-04-01
|
| Schriftenreihe: | European Psychiatry |
| Schlagworte: | |
| Online-Zugang: | https://www.cambridge.org/core/product/identifier/S0924933821021246/type/journal_article |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|